LONDON - Belluscura has entered into a joint venture with Separation Design Group and an undisclosed major medical device company to develop oxygen-based wound care solutions.
In the first update since 2010, the American Heart Association and the American Red Cross have included how to treat opioid overdoses and open chest wounds, among other things. Other industry news ...
Molecular Cellular Pharmacology Graduate Program, University of Wisconsin-Madison, Madison, USA Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan ...